Novartis AG ADR (NVS) Stock Forecast & Price Target
Novartis AG ADR · NYSE
$159.80+3.69 (+2.37%)
15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 5 firms covering Novartis AG ADR, 2 rate it Buy or better, 2 sit at Hold, and 1 rate it Sell or worse, a moderate buy consensus. Targets span $118.00 to $170.00, a moderate spread. The average target of $144.00 sits 10% below the current $159.80. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $2.02 next quarter toward $9.82 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 ratings
Moderate Buy
Strong Buy00%
Buy240%
Hold240%
Sell120%
Strong Sell00%
Based on 5 analysts giving stock ratings to Novartis AG ADR.
As of Jul, 2 of 5 firms rate NVS a Buy (2 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
NVS EPS & revenue forecast
EPS · NEXT QUARTER
$2.02
Range $2.02 – $2.02 · 1 analysts · -1% YoY
Next period, 1 analysts expect Novartis AG ADR to earn $2.02 a share (range $2.02 – $2.02), versus $2.03 a year earlier. Full-year consensus is $8.83, growing to $9.82 the year after.
REVENUE · NEXT QUARTER
$14.9B
Range $14.4B – $15.2B · 1 analysts · +7% YoY
Revenue is expected to reach $14.9B (range $14.4B – $15.2B), +7.4% year-over-year. Full-year consensus is $57.5B, rising to $61.0B next year.
Top analysts covering Novartis AG ADR
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on NVS.
#1
JQ
James Quigley
Goldman Sachs
Sell
$118.00-26.2% to target
Coverage
—
+ Follow
#2
RV
Richard Vosser
JP Morgan
Buy
No targeton NVS
Coverage
—
+ Follow
#3
KH
Kerry Holford
Berenberg Bank
Hold
$141.00-11.8% to target
Coverage
—
+ Follow
#4
SS
Steve Scala
TD Cowen
Hold
$180.00+12.6% to target
Coverage
—
+ Follow
#5
EF
Emily Field
Barclays
Hold
No targeton NVS
Coverage
—
+ Follow
NVS stock forecast FAQ
What is NVS's average 12-month price target?+
The 2 analysts with a live target average $144.00 for Novartis AG ADR over the next 12 months, ranging from a $170.00 high to a $118.00 low.
Is NVS stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 5 analyst ratings, 2 are Buy or Strong Buy, 2 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for NVS?+
The Street-high target is $170.00 (Morgan Stanley), and the Street-low is $118.00 (Goldman Sachs). The average of all 2 active targets is $144.00.
How many Wall Street analysts cover NVS?+
5 analysts have an active rating on Novartis AG ADR, and 2 firms carry a live 12-month price target.
Who is the most accurate analyst covering NVS?+
Among analysts who currently cover NVS, James Quigley of Goldman Sachs has the strongest overall Quantellect track record. Their current call is Sell with a $118.00 target.
What is Novartis AG ADR's projected EPS for next quarter?+
The consensus estimate is $2.02 per share (range $2.02 – $2.02) across 1 analysts. Full-year EPS is projected at $8.83, rising to $9.82 the following year.
How much revenue is Novartis AG ADR expected to report next quarter?+
Consensus revenue is $14.9B (range $14.4B – $15.2B). Full-year revenue is projected at $57.5B, growing to $61.0B next year.
Have analysts been upgrading or downgrading NVS lately?+
As of Jul, 2 of 5 firms rate NVS a Buy (2 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their NVS calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
